eflornithine has been researched along with Teratocarcinoma in 2 studies
Eflornithine: An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway.
eflornithine : A fluoroamino acid that is ornithine substituted by a difluoromethyl group at position 2.
Teratocarcinoma: A malignant neoplasm consisting of elements of teratoma with those of embryonal carcinoma or choriocarcinoma, or both. It occurs most often in the testis. (Dorland, 27th ed)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Frostesjö, L | 1 |
Holm, I | 1 |
Grahn, B | 1 |
Page, AW | 1 |
Bestor, TH | 1 |
Heby, O | 2 |
Bjersing, JL | 1 |
Brorsson, A | 1 |
2 other studies available for eflornithine and Teratocarcinoma
Article | Year |
---|---|
Interference with DNA methyltransferase activity and genome methylation during F9 teratocarcinoma stem cell differentiation induced by polyamine depletion.
Topics: Adenosylmethionine Decarboxylase; Animals; Cell Differentiation; Cytosine; DNA Methylation; DNA Modi | 1997 |
Increased expression of c-jun, but not retinoic acid receptor beta, is associated with F9 teratocarcinoma stem cell differentiation induced by polyamine depletion.
Topics: Animals; Cell Differentiation; Eflornithine; Embryonal Carcinoma Stem Cells; Enzyme Inhibitors; Gene | 1997 |